1 year return (CAGR)
-17.24%
Audax Renovables S.A. Exchange (MC, EUR)
ADX.MC
1.15
+0.02 (+1.95%)
UtilitiesUtilities - Renewable
Loading...
3 year return (CAGR)
-2.94%
5 year return (CAGR)
-4.23%
10 year return (CAGR)
9.61%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
513.41M
Price/Sales
0.28
Ent value
1.44B
Price/Book
2.15
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.93%
Trailing P/E
30.16
PEG
-
Forward P/E
10.02
EPS growth
-6.20%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.15 |
| Daily high | 1.16 |
| Daily low | 1.14 |
| Daily Volume | 141K |
| All-time high | 9.72 |
| 1y analyst estimate | 2.35 |
| Beta | 1.15 |
| EPS (TTM) | 0.04 |
| Dividend per share | 0.00 |
| Ex-div date | 1 Jul 2026 |
| Next earnings date | 28 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ADX.MC | S&P500 | |
| Current price drop from All-time high | -88.15% | -1.96% |
| Highest price drop | -97.22% | -56.47% |
| Date of highest drop | 25 Apr 2013 | 9 Mar 2009 |
| Avg drop from high | -80.31% | -10.68% |
| Avg time to new high | 70 days | 12 days |
| Max time to new high | 4897 days | 1805 days |
News
Novartis AG (NYSE:NVS) has discontinued development of VHB937, also known as lifonebart, after the experimental ALS drug failed to meet both its primary and secondary endpoints in a Phase II trial inv...
September 22, 2026
Telix Pharmaceuticals announced a merger with privately held ITM on Monday, leading the stock to crash despite bullish views from analysts.
September 21, 2026
NVS' Cosentyx wins a positive EU opinion for PMR, backed by late-stage data, potentially expanding its use beyond existing inflammatory conditions.
September 21, 2026
Novo Nordisk's (NVO) US-listed shares declined as the Danish drugmaker unveiled its long-term growth
September 21, 2026
Press release - Regulated Information Melexis: update on the share buy-back program Ieper, Belgium – 21 September 2026, 17.45 hrs CET Melexis reports the purchase of 14,519 Melexis shares on Euronext ...
September 21, 2026
Covivio (ENXTPA:COV) has drawn fresh attention after recent share price weakness, with the stock down about 9% over the past month and 11% over the past 3 months. That recent slide comes after a weake...
September 20, 2026
Investing.com -- European assets may offer investors advantages that are being overlooked as markets remain heavily focused on U.S. technology leadership, according to Macquarie Global Strategy, which...
September 20, 2026
Edison (BIT:EDNR) traded at €1.894 at the last close, with the share price lower over the past day, week, month, past 3 months and year to date. That recent slide in Edison’s share price adds to a wea...
September 19, 2026